posted by Thom Holwerda on Wed 1st Jul 2015 21:44 UTC
Icon

A recent draft of the Trans-Pacific Partnership free-trade deal would give U.S. pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in U.S. law.

This article focuses on pharmaceuticals, but just imagine what similar restrictions would mean for technology. This is disastrous.


e p (6)    31 Comment(s)

Technology White Papers

See More